Keyword

CYP2C19*3

Description: CYP2C19*3 is a loss-of-function variant of the CYP2C19 gene, relevant to pharmacogenetic differences in drug metabolism and treatment response.
OpenAlex ID: keywords/cyp2c19-3
2004 · M SCORDO, Achille P Caputi, et al. · Pharmacological Research · 254
2003 · Takaharu Mizutani · Drug Metabolism Reviews · 252
1998 · Ronald J. Ferguson, Sonia M.F. De Morais, et al. · Journal of Pharmacology and Experimental Therapeutics · 224
1998 · Miyuki Kimura, Ichiro Ieiri, et al. · Therapeutic Drug Monitoring · 212
1994 · S M Barlow · Occupational and Environmental Medicine · 203
2015 · I Fricke-Galindo, C Céspedes-Garro, et al. · The Pharmacogenomics Journal · 187
2006 · K OBAYASHI, K NAKAMURA, et al. · Clinical Pharmacology & Therapeutics · 150
1996 · Hyung-Keun Roh, Marja-Liisa Dahl, et al. · Pharmacogenetics · 128
2004 · Rosemary Jose, Adithan Chandrasekaran, et al. · Fundamental and Clinical Pharmacology · 120
2001 · Collet Dandara, Collen Mutowembwa Masimirembwa, et al. · European Journal of Clinical Pharmacology · 115
2009 · Toshikazu Jinnai, Hisanori Horiuchi, et al. · Circulation Journal · 109
2001 · W. Tamminga, J. Wemer, et al. · European Journal of Clinical Pharmacology · 102
1998 · Karin Herrlin, Amos Y. Massele, et al. · Clinical Pharmacology & Therapeutics · 102
2010 · Takahisa Furuta, Takayuki Iwaki, et al. · British Journal of Clinical Pharmacology · 99
2008 · Tommy Andersson, Lars Weidolf · Clinical Drug Investigation · 95
2005 · Hiromi Fukushima-Uesaka, Yoshiro Saito, et al. · Drug Metabolism and Pharmacokinetics · 86
1994 · U A Meyer · Proceedings of the National Academy of Sciences · 85
2017 · Kittika Yampayon, Chonlaphat Sukasem, et al. · European Journal of Clinical Pharmacology · 81
2003 · C. Adithan, N. Gerard, et al. · British Journal of Clinical Pharmacology · 76
Works count: 508
Citation count: 8,071
Year
Topic
Type